UPDATE: Merck KGaA Acquires Biotest's Microbiology Business
22 Mars 2011 - 12:29PM
Dow Jones News
Germany's Merck KGaA (MRK.XE) said Tuesday it has entered into a
definitive agreement to acquire the microbiology business of
Biotest AG (BIO.XE), Germany.
MAIN FACTS:
-A Merck spokesman Tuesday said the purchase price was up to
EUR101 million before tax.
-The business has approximately 290 employees and generated
sales of approximately EUR50 million in 2010.
-This business comprises heipha Dr. Muller GmbH, located in
Eppelheim, Germany, as well as the Hycon business located in
Dreieich, the subsidiaries in France, Japan and in the USA as well
as further activities and employees in several European
countries.
-The agreement is subject to antitrust approvals in Germany and
Austria.
-Closing of the transaction is expected in the second half of
2011.
-Frankfurt Bureau, Dow Jones Newswires; 49-69-29725-500
Biotest (PK) (USOTC:BTTAY)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Biotest (PK) (USOTC:BTTAY)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024
Real-Time news about Biotest AG (PK) (OTCMarkets): 0 recent articles
Plus d'articles sur Biotest AG ADS